Chile vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2023
Chile rank
1st
Saint Vincent and the Grenadines rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Saint Vincent and the Grenadines
How they compare
Chile currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2005 it was Saint Vincent and the Grenadines ahead.
Chile ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Saint Vincent and the Grenadines in 2.
Head to head by decade
| Decade | Chile | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 86.0% | 82.8% | Saint Vincent and the Grenadines |
| 2010s | 46.0% | 72.8% | 26.8% | Saint Vincent and the Grenadines |
| 2020s | 94.0% | 75.0% | 19.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Saint Vincent and the Grenadines?
- Chile, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Saint Vincent and the Grenadines?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Saint Vincent and the Grenadines?
- 13 years are reported by both, from 2005 to 2023.
- How do Chile and Saint Vincent and the Grenadines rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.